New knowledgebase with expert-curated pharmacogenomic content on how genetic variations influence drug response Centralized data and automated annotation enable scientific and translational researchers to rapidly generate genomic and drug insights Enhancing the understanding of pharmacogenomics is crucial to, reduce treatment-related side effects and optimizing drug development and delivery Redwood City, California – QIAGEN Digital Insights […]

MENLO PARK, Calif. — PacBio (Nasdaq: PACB), a leading developer of high-quality, highly accurate genomic sequencing solutions, today announced the inclusion of the Onso short-read sequencing platform in the 10x Genomics Compatible Partner Program. The 10x Genomics Compatible Partner Program recognizes instruments and workflows compatible with 10x Genomics’ products and applications, thereby broadening the range […]

Oncomine Dx Target Test to Identify Patients Eligible for Servier’s VORANIGO® (vorasidenib) tablet, the only FDA-approved treatment for Grade 2 IDH-mutant glioma CARLSBAD, Calif. — Thermo Fisher Scientific, the world leader in serving science, has received approval from the U.S. Food and Drug Administration (FDA) for its Ion Torrent™ Oncomine™ Dx Target Test as a companion […]

PARIS — Okomera announces Bpifrance funding to develop and standardize novel CRISPR screening assay to accelerate drug discovery in oncology with leading cancer research center of Marseille, CRCM. Okomera is developing desktop platform for automated organoid screening using droplet-microfluidics and AI to accelerate drug discovery. Their patented tech developed after 10 years of research at Pasteur Institute and […]

Gulf Scientific Corporation (GSC), a leading provider of laboratory solutions in the Gulf Cooperation Council (GCC), proudly announces a new strategic partnership with SOPHiA GENETICS, a global pioneer in data-driven medicine, headquartered in Switzerland. GSC will now represent SOPHiA GENETICS across the UAE, Saudi Arabia, Oman, Qatar, and Bahrain, delivering their cutting-edge technologies to healthcare […]

SAN DIEGO — Proteintech Genomics, a leader in antibody-based multiplexed solutions for single-cell multiomics, today announced the launch of its MultiPro® Human Discovery Panel, a groundbreaking antibody panel designed to transform single-cell multiomics research. This new panel enables scientists to profile 325 proteins alongside whole transcriptome analysis within single cells, offering a multiomic approach that […]

On October 10, Shimadzu signed an agreement related to comprehensive collaboration with Waseda University, with the aim of promoting mutual collaboration, including research and development, and the fostering of human resources. Based on this collaborative agreement, both parties will work to develop new products and foster highly specialized human resources through collaborative research aiming at […]

Founding CEO Thomas Ybert transitions to Chief Scientific Officer role to underscore company’s ongoing commitment to scientific discovery and innovation PARIS and DALY CITY, Calif. – DNA Script, a leader in enzymatic DNA synthesis, today announced the appointment of Marc Montserrat as its new Chief Executive Officer. In addition, founding CEO Thomas Ybert, PhD, has transitioned to a new Chief Scientific Officer role, where he will continue to […]

Enables content for newly launched Illumina MiSeq™ i100 and expands Illumina oncology panel portfolio to include targeted liquid biopsy panels NATICK, Mass. — Pillar Biosciences, Inc., the leader in Decision Medicine™, has today announced an expansion of their existing partnership with Illumina, through which a broader portfolio of Pillar’s oncoReveal™ NGS panels will now be offered directly by Illumina. […]

Element Biosciences has partnered with Integrated DNA Technologies (IDT) and Twist Bioscience to provide the necessary exome-targeting tools for the Trinity workflow SAN DIEGO, CA – Element Biosciences, Inc., a developer of pioneering technologies to empower science, today introduced Trinity™ – an innovative solution that simplifies target capture sequencing by eliminating or moving traditionally time-consuming steps to the AVITI™ […]